Xin Wang
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 24
- COVID-19 Clinical Research Studies 18
- Immunology top 2%
- interferon and immune responses 20
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 19
- Advanced biosensing and bioanalysis techniques 9
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds 10
- Virology top 5%
-
- Cytokine Signaling Pathways and Interactions 22
-
- Computational Drug Discovery Methods 19
- Journals
- Blood (5 papers)European Journal of Medicinal Chemistry (5 papers)Frontiers in Microbiology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xin Wang
272 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Infectious Diseases 1.5k
- Immunology 1.3k
- Molecular Biology 2.8k
- Pharmacology 298
- Virology 154
Countries citing papers authored by Xin Wang
This map shows the geographic impact of Xin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Wang more than expected).
Fields of papers citing papers by Xin Wang
This network shows the impact of papers produced by Xin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Wang. The network helps show where Xin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 22 | |
| 12 | 2023 | 13 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 9 | |
| 17 | 2019 | 27 | |
| 18 | 2019 | 5 | |
| 19 | 2015 | 37 | |
| 20 | 2015 | 21 |
About Xin Wang
Xin Wang is a scholar working on Infectious Diseases, Immunology and Oncology, having authored 287 papers that have together received 7.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (24 papers), Cytokine Signaling Pathways and Interactions (22 papers), interferon and immune responses (20 papers), RNA Interference and Gene Delivery (19 papers), Computational Drug Discovery Methods (19 papers), COVID-19 Clinical Research Studies (18 papers), Pharmacological Effects of Natural Compounds (10 papers) and Advanced biosensing and bioanalysis techniques (9 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Immunology (1.3k citations) and Molecular Biology (2.8k citations). Xin Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiahui Zheng, Shao Li, Ziyi Wang, Olof Ramström, Mingdi Yan, Siyuan Ding, Ruochen Zang, Jianxin You, Kevin Brulois and Harry B. Greenberg. Their work appears in journals such as Blood, European Journal of Medicinal Chemistry, Frontiers in Microbiology, Journal of Biological Chemistry and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.